BioengineeringbioRxivPreprint
A Nanoparticle RIG-I Agonist for Cancer Immunotherapy
L. Wang-Bishop, M. Wehbe, L. E. Pastora…·J. T. Wilson
This paper develops SLR-LNPs, a nanoparticle-based RIG-I agonist, showing enhanced tumor immunogenicity and improved response to immune checkpoint inhibitors in mouse cancer models.
DOI 10.1101/2023.04.25.537919